Butabarbital decreases consequences of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of CYP3A4 inducers might decrease sufentanil ranges and efficacy, perhaps precipitating withdrawal syndrome in sufferers who may have designed Bodily dependence to sufentanil. Discontinuation of concomitantly employed CYP3A4 ... https://mickc579acc4.ktwiki.com/user